HAYWARD, Calif.--(BUSINESS WIRE)--RefleXion Medical, a therapeutic oncology company, today announced that the first patient has completed treatment with SCINTIX™ biology-guided radiotherapy on the ...
Actinium-225, an alpha-emitting radiopharmaceutical, targets cancer cells precisely, sparing healthy tissue, and is being trialed for advanced breast cancer in the U.S. The phase 1b/2 trial involves ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results